A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Velafermin (Primary)
- Indications Stomatitis
- Focus Therapeutic Use
- Sponsors CuraGen Corporation
Most Recent Events
- 17 Mar 2016 New trial record